<i>KRAS</i> Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?

<i>KRAS</i> Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?

Background: Genetic evaluation is essential in assessing colorectal cancer (CRC) and colorectal liver metastasis (CRLM). The aim of this study was to determine the pragmatic value of <i>KRAS</i> on oncological outcomes after CRLM according to the ESMO recommendations and to query whether...

Full description

Bibliographic Details
Main Authors: Olga Morató, Maria Villamonte, Patricia Sánchez-Velázquez, Eva Pueyo-Périz, Luís Grande, Benedetto Ielpo, Edoardo Rosso, Alessandro Anselmo, Fernando Burdío
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Healthcare
Subjects:
<i>KRAS</i> oncogene
colorectal liver metastases
tumour burden score
synchronic tumours
Online Access:https://www.mdpi.com/2227-9032/10/3/472

Internet

https://www.mdpi.com/2227-9032/10/3/472

Similar Items